Distribution of sputum inflammatory phenotypes in patients with, or without, detectable virus at exacerbation (n.s.). Paucigranulocytic (< 3% eosinophils & < 61% neutrophils), eosinophilic (≥ 3% eosinophils & < 61% neutrophils), neutrophilic (< 3% eosinophils & ≥ 61% neutrophils), mixed granulocytic (≥ 3% eosinophils & ≥ 61% neutrophils).